Seòmar agus comataidhean

NHS Boards continue to undertake improvement work to ensure that women diagnosed with ovarian cancer can access surgery. The Scottish Government continues to seek regular updates on progress and to work with them to improve overall care for patients with ovarian cancer regardless of where they live.

Further to this, Scottish Government has provided £106 million planned care funding in 2025/26 across NHS Scotland, with £14.23 million of this directed towards Cancer Waiting Times.

This is all part of our programme to drive up productivity and tackle waiting lists, supported by the Centre for Sustainable Delivery (CfSD). Together, our actions will further enable NHS Scotland to maximise capacity, build greater resilience and deliver year-on-year reductions in the number of patients who have waited too long for treatment.

Local authorities retain the statutory responsibility for the delivery of education in Scotland. Decisions around the delivery of additional needs support and the minimum levels of staff to meet local level needs are matters for education authorities.

We have 17,046 pupil support assistants in Scotland – the second highest level on record and an increase of nearly 1,800 since 2020. This is a direct result of our continued investment of £15m each year to help them respond to the individual needs of children and young people and maintains our record levels of investment in these staff.

It is a matter for Health Boards to consider the implementation of any new medicine to meet the needs of their local population. However, in response to concerns raised regarding access to givinostat in Scotland, the Cabinet Secretary has met with the four health boards who provide regional services across Scotland for children and adults with neuromuscular disorders, including Duchenne Muscular Dystrophy (DMD). He has asked them to set out their timelines and approaches to the families who have children with DMD, and this is now underway. In addition, the Chief Pharmaceutical Officer (CPO) has been assured that the consultants have reviewed all those who eligible to ensure fair and equitable access across Scotland.

NHS Greater Glasgow and Clyde have and are continuing to take action to simplify scheduling of these complex cases. Following updates provided by NHS Greater Glasgow and Clyde on 19 February and 9 June, I will be meeting with members of the board and clinicians in September 2025 to seek further clarity in terms of progress made.

The Scottish Government collects and publishes data on the total number of diversion from prosecution cases commenced for people aged under 18, this is published in the Justice Social Work Statistics in Scotland: 2023-24 - Part 1.

Over the past five years a total of 3,444 diversion from prosecution cases were started for individuals under 18. However, information on the specific alleged offence in each case is not available.

The South East Scotland Cancer Network (SCAN) continue to focus on reducing waiting times and improving outcomes for people diagnosed with ovarian cancer. They have made recent innovations in both the pre-diagnosis and post-diagnosis parts of the pathway:

• Pre diagnosis: patients referred with suspected ovarian cancer automatically receive a CT scan appointment and should the scan show any suspicious features, the multi-disciplinary team will review and an action plan will be formalised. They report that this has significantly decreased waiting times.
• Post diagnosis: 10 dedicated advanced ovarian cancer surgery lists are offered each week supported by the specialist gynae-oncology team and the colorectal and hepato-biliary surgery teams, as appropriate, aiming to improve post-surgery outcomes including survival rates.

In partnership with NHS Scotland colleagues, the Scottish Government are developing tools to support GP practices to proactively identify people on topical steroids so that their treatment can be reviewed.

It is a matter for individual Health Boards to consider the implementation of any new medicine to meet the needs of their local population, and they are responsible for funding new medicines from their local medicines budgets. However, the Scottish Government has committed to investing rebates from the Voluntary Scheme for Branded Medicines, Pricing Access and Growth (VPAG) to fund the New Medicines Fund (NMF), which provides additional top-up funding to territorial Health Boards to support the cost of introducing new medicines. Since 2014-15, £906 million has been made available to Health Boards through this fund. In addition, a national process is in place, administered by National Services Scotland National Procurement (NP), to review early access programmes on a ‘once for Scotland’ basis on behalf of Scottish Health Boards.

Local authorities are supported in fulfilling their duties under the 2004 Act through the statutory code of practice on additional support for learning.

In instances where parents/carers are concerned that education authorities may not be fulfilling their duties under the Education (Additional Support for Learning) (Scotland) Act 2004, there are a range of dispute resolution mechanisms available under the 2004 Act. These include mediation, independent adjudication, and referral to the Additional Support Needs Tribunal.

Under section 70 of the Education (Scotland) Act 1980 any interested party can make a reference to the Scottish Ministers that a responsible body (the managers of a school or education establishment, an education authority or other persons) has failed to discharge a duty imposed on them by or for the purposes of any enactment relating to education.

I refer the member to the answer to question S6W-38143 on 13 June 2025.

Following extensive stakeholder engagement and data review, we published the first optimal cancer diagnostic pathways on lung, head & neck and colorectal cancers. Prioritisation of the next optimal diagnostic pathways to be developed in the subsequent Cancer Action Plan(s) will be based on data and stakeholder engagement.

A clinical review of the Scottish Referral Guidelines for Suspected Cancer has just concluded to help ensure the right person is on the right pathway at the right time. For the first time, the review has ensured the inclusion of a nationally agreed non-specific symptoms referral guideline, as well as an update to the guidance for urgent referral for suspected brain tumours. Publication of the reviewed guidelines is expected this month.

The National Headache Pathway was published by the Centre for Sustainable Delivery, has been developed to support the assessment, diagnosis and management of primary headache disorders. This includes the red flag symptoms that indicate the need for urgent and/or emergency assessment to exclude a secondary cause, such as a brain tumours.

All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers